Hunter Perkins Capital Management LLC Takes $764,000 Position in Quaker Chemical Co. (NYSE:KWR)

Hunter Perkins Capital Management LLC acquired a new position in shares of Quaker Chemical Co. (NYSE:KWR - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 5,425 shares of the specialty chemicals company's stock, valued at approximately $764,000.

A number of other institutional investors have also made changes to their positions in the stock. Harbor Capital Advisors Inc. grew its position in shares of Quaker Chemical by 112.8% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 8,903 shares of the specialty chemicals company's stock worth $1,500,000 after buying an additional 4,720 shares during the period. Cerity Partners LLC raised its holdings in Quaker Chemical by 485.5% in the third quarter. Cerity Partners LLC now owns 64,631 shares of the specialty chemicals company's stock worth $10,890,000 after purchasing an additional 53,592 shares during the period. JPMorgan Chase & Co. boosted its position in shares of Quaker Chemical by 16.6% during the third quarter. JPMorgan Chase & Co. now owns 636,739 shares of the specialty chemicals company's stock worth $107,284,000 after purchasing an additional 90,726 shares in the last quarter. Seizert Capital Partners LLC grew its holdings in shares of Quaker Chemical by 122.7% in the 3rd quarter. Seizert Capital Partners LLC now owns 20,067 shares of the specialty chemicals company's stock valued at $3,381,000 after buying an additional 11,058 shares during the period. Finally, Renaissance Technologies LLC increased its position in shares of Quaker Chemical by 37.4% in the 2nd quarter. Renaissance Technologies LLC now owns 21,300 shares of the specialty chemicals company's stock valued at $3,615,000 after buying an additional 5,800 shares in the last quarter. 77.46% of the stock is owned by institutional investors and hedge funds.

Quaker Chemical Stock Up 4.2 %

Shares of Quaker Chemical stock traded up $5.84 during trading on Monday, reaching $144.21. The stock had a trading volume of 184,122 shares, compared to its average volume of 178,676. The company has a market capitalization of $2.57 billion, a price-to-earnings ratio of 21.15, a P/E/G ratio of 1.53 and a beta of 1.39. The stock has a fifty day moving average price of $145.55 and a two-hundred day moving average price of $159.16. The company has a current ratio of 2.54, a quick ratio of 1.88 and a debt-to-equity ratio of 0.48. Quaker Chemical Co. has a 52 week low of $124.66 and a 52 week high of $207.83.

Quaker Chemical (NYSE:KWR - Get Free Report) last released its earnings results on Thursday, October 31st. The specialty chemicals company reported $1.89 EPS for the quarter, missing the consensus estimate of $2.08 by ($0.19). The firm had revenue of $462.27 million during the quarter, compared to the consensus estimate of $469.17 million. Quaker Chemical had a net margin of 6.58% and a return on equity of 10.10%. The company's revenue was down 5.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.05 EPS. Sell-side analysts predict that Quaker Chemical Co. will post 7.75 EPS for the current fiscal year.

Quaker Chemical Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Friday, January 17th will be given a dividend of $0.485 per share. The ex-dividend date is Friday, January 17th. This represents a $1.94 annualized dividend and a yield of 1.35%. Quaker Chemical's dividend payout ratio (DPR) is presently 28.45%.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the company. Deutsche Bank Aktiengesellschaft lowered their price target on Quaker Chemical from $190.00 to $182.00 and set a "buy" rating for the company in a report on Monday, November 4th. StockNews.com raised Quaker Chemical from a "hold" rating to a "buy" rating in a research note on Thursday, November 28th. Piper Sandler restated a "neutral" rating and set a $170.00 target price (down from $200.00) on shares of Quaker Chemical in a report on Tuesday, January 7th. Finally, Royal Bank of Canada cut their price target on shares of Quaker Chemical from $195.00 to $180.00 and set an "outperform" rating on the stock in a research note on Monday, November 4th.

Insiders Place Their Bets

In other Quaker Chemical news, EVP Jeewat Bijlani sold 645 shares of the company's stock in a transaction on Friday, November 22nd. The shares were sold at an average price of $165.98, for a total transaction of $107,057.10. Following the sale, the executive vice president now directly owns 4,747 shares of the company's stock, valued at approximately $787,907.06. This represents a 11.96 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, SVP David Slinkman sold 1,700 shares of the company's stock in a transaction on Monday, November 25th. The stock was sold at an average price of $167.80, for a total transaction of $285,260.00. Following the sale, the senior vice president now directly owns 2,825 shares in the company, valued at $474,035. This trade represents a 37.57 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.30% of the company's stock.

Quaker Chemical Company Profile

Quaker Chemical Corporation, together with its subsidiaries, develops, produces, and markets various formulated specialty chemical products for a range of heavy industrial and manufacturing applications in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It offers metal removal fluids, cleaning fluids, corrosion inhibitors, metal drawing and forming fluids, die-cast mold releases, heat treatment and quenchants, metal forging fluids, hydraulic fluids, specialty greases, offshore sub-sea energy control fluids, rolling lubricants, rod and wire drawing fluids, and surface treatment chemicals.